Open Government Portal
Fisheries and Oceans Canada’s (DFO’s) conditions of licence for marine finfish aquaculture contain monitoring and intervention requirements to minimize the potential exposure of wild and farmed fish to sea lice. The Industry Sea Lice Abundance Counts report is updated monthly. It shows which Atlantic salmon farms were actively raising fish during the month and the results of industry's monthly sea lice monitoring.
Please see the Open Data page for DFO sea lice audits of BC marine finfish aquaculture sites to see data from 2011 to 2015.
Related links:
- Infographic: …
The Government of Canada Core Subject Thesaurus is a bilingual thesaurus consisting of terminology which represents all the fields treated in information resources of the Government of Canada. It contains 4,991 terms in English and 5,059 in French, including 2,299 preferred terms in English and 2,300 in French. All fields of knowledge are represented in the thesaurus, to varying degrees. Because of the great variety of subjects covered by the thesaurus, its terminology is rather general. By design, it does not include specialized terminology used in specific and limited disciplines.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products
Briefing binder used by Minister Petitpas Taylor before the Senate Standing Committee on Official Languages (OLLO) on June 5, 2023
The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to the Prescription Drug List (PDL) for human and veterinary use.
This monthly publication is intended primarily for healthcare professionals and includes information on pharmaceuticals, biologics, medical devices and natural health products.